Cargando…
Hypofractionated chemoradiotherapy for locally advanced non-small cell lung cancer: Is split-dose chemotherapy safer than full dose chemotherapy?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299849/ https://www.ncbi.nlm.nih.gov/pubmed/32562737 http://dx.doi.org/10.1016/j.radonc.2020.06.020 |
| _version_ | 1783547453685891072 |
|---|---|
| author | Iqbal, Muhammad Shahid McMenemin, Rhona Greystoke, Alastair |
| author_facet | Iqbal, Muhammad Shahid McMenemin, Rhona Greystoke, Alastair |
| author_sort | Iqbal, Muhammad Shahid |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7299849 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72998492020-06-18 Hypofractionated chemoradiotherapy for locally advanced non-small cell lung cancer: Is split-dose chemotherapy safer than full dose chemotherapy? Iqbal, Muhammad Shahid McMenemin, Rhona Greystoke, Alastair Radiother Oncol Letter to the Editor Published by Elsevier B.V. 2021-01 2020-06-18 /pmc/articles/PMC7299849/ /pubmed/32562737 http://dx.doi.org/10.1016/j.radonc.2020.06.020 Text en Crown Copyright © 2020 Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Iqbal, Muhammad Shahid McMenemin, Rhona Greystoke, Alastair Hypofractionated chemoradiotherapy for locally advanced non-small cell lung cancer: Is split-dose chemotherapy safer than full dose chemotherapy? |
| title | Hypofractionated chemoradiotherapy for locally advanced non-small cell lung cancer: Is split-dose chemotherapy safer than full dose chemotherapy? |
| title_full | Hypofractionated chemoradiotherapy for locally advanced non-small cell lung cancer: Is split-dose chemotherapy safer than full dose chemotherapy? |
| title_fullStr | Hypofractionated chemoradiotherapy for locally advanced non-small cell lung cancer: Is split-dose chemotherapy safer than full dose chemotherapy? |
| title_full_unstemmed | Hypofractionated chemoradiotherapy for locally advanced non-small cell lung cancer: Is split-dose chemotherapy safer than full dose chemotherapy? |
| title_short | Hypofractionated chemoradiotherapy for locally advanced non-small cell lung cancer: Is split-dose chemotherapy safer than full dose chemotherapy? |
| title_sort | hypofractionated chemoradiotherapy for locally advanced non-small cell lung cancer: is split-dose chemotherapy safer than full dose chemotherapy? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299849/ https://www.ncbi.nlm.nih.gov/pubmed/32562737 http://dx.doi.org/10.1016/j.radonc.2020.06.020 |
| work_keys_str_mv | AT iqbalmuhammadshahid hypofractionatedchemoradiotherapyforlocallyadvancednonsmallcelllungcancerissplitdosechemotherapysaferthanfulldosechemotherapy AT mcmeneminrhona hypofractionatedchemoradiotherapyforlocallyadvancednonsmallcelllungcancerissplitdosechemotherapysaferthanfulldosechemotherapy AT greystokealastair hypofractionatedchemoradiotherapyforlocallyadvancednonsmallcelllungcancerissplitdosechemotherapysaferthanfulldosechemotherapy |